Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
About this item
Full title
Author / Creator
Charytan, David M , Mahaffey, Kenneth W , Jardine, Meg J , Cannon, Christopher P , Neal, Bruce , Lambers Heerspink, Hiddo J , Agarwal, Rajiv , Bakris, George L , de Zeeuw, Dick , Levin, Adeera , Pollock, Carol , Zhang, Hong , Zinman, Bernard , Rosenthal, Norman , Perkovic, Vlado , Di Tanna, Gian Luca , Yu, Jie , Rogers, Kris , Arnott, Clare and Wheeler, David C
Publisher
England: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
England: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
IntroductionRelationships between glycemic-lowering effects of sodium glucose co-transporter 2 inhibitors and impact on kidney and cardiovascular outcomes are uncertain.Research design and methodsWe analyzed 4395 individuals with prebaseline and postbaseline hemoglobin A1c (HbA1c) randomized to canagliflozin (n=2193) or placebo (n=2202) in The Cana...
Alternative Titles
Full title
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
Authors, Artists and Contributors
Author / Creator
Mahaffey, Kenneth W
Jardine, Meg J
Cannon, Christopher P
Neal, Bruce
Lambers Heerspink, Hiddo J
Agarwal, Rajiv
Bakris, George L
de Zeeuw, Dick
Levin, Adeera
Pollock, Carol
Zhang, Hong
Zinman, Bernard
Rosenthal, Norman
Perkovic, Vlado
Di Tanna, Gian Luca
Yu, Jie
Rogers, Kris
Arnott, Clare
Wheeler, David C
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_83663dfd99b5429482efb801e4aa82d8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_83663dfd99b5429482efb801e4aa82d8
Other Identifiers
ISSN
2052-4897
E-ISSN
2052-4897
DOI
10.1136/bmjdrc-2022-003270
